Back to Search
Start Over
Neurobiological mechanisms of antiallodynic effect of transcranial direct current stimulation (tDCS) in a mice model of neuropathic pain
- Source :
- Repositório Institucional do Centro Universitário La Salle, Universidade La Salle (UNILASALLE), instacron:UNILASALLE
- Publication Year :
- 2018
- Publisher :
- Elsevier, 2018.
-
Abstract
- Submitted by DSpace Unilasalle (dspace@unilasalle.edu.br) on 2021-08-03T14:45:27Z No. of bitstreams: 1 asouza.etal.pdf: 1041409 bytes, checksum: 7c3564560a848231e34c4d8068854532 (MD5) Made available in DSpace on 2021-08-03T14:45:27Z (GMT). No. of bitstreams: 1 asouza.etal.pdf: 1041409 bytes, checksum: 7c3564560a848231e34c4d8068854532 (MD5) Previous issue date: 2018 Background: Neuropathic pain is relatively common and occurs in approximately 6–8% of the population. It is associated with allodynia and hyperalgesia. Thus, non-pharmacological treatments, such as transcranial direct current stimulation (tDCS) may be useful for relieving pain. Objectives: This study aimed to investigate the antiallodynic effect of tDCS in a mice model of neuropathic pain, and the underlying neurotransmission systems that could drive these effects. Methods: Male, Swiss mice, weighing 25–35 g, were subjected to partial sciatic nerve ligation (PSNL). Allodynia was assessed using a Von Frey filament (0.6 g). First, the behavioral time-course of these mice was assessed after 5, 10, 15 and 20 min of tDCS (0.5 mA). Second, the mice that underwent PSNL were assigned to either the tDCS (0.5 mA, 15 min) or tDCS sham group, and further assigned to receive either saline or a drug (i.e., naloxone, yohimbine, a-methyl-p-tyrosine, q-chlorophenylalanine methyl ester, caffeine, 1,3-dipropyl-8-cyclopentylxanthine, AM281, AM630, flumazenil, MK-801, or lidocaine). Results: The antiallodynic effect of tDCS lasted 2 h and 4 h, after 10 min and 15 or 20 min of treatment, respectively (P < .001, P < .01, and P < .05, respectively). The antiallodynic effect of tDCS was associated with all the systems that were analyzed, i.e., the opioidergic (P < .01), adenosinergic (P < .001), serotonergic (P < .01), noradrenergic (P < .001), cannabinoid (P < .001), GABAergic, and glutamatergic (P < .001) systems. Lidocaine did not reverse the antiallodynic effect of tDCS (P > .05). Conclusion: The antiallodynic effect of tDCS was associated with different neurotransmitters systems; the duration of these after-effects depended on the time exposure to tDCS.
- Subjects :
- Flumazenil
Male
0301 basic medicine
Narcotic Antagonists
medicine.medical_treatment
Chronic pain
(+)-Naloxone
Transcranial Direct Current Stimulation
tDCS
Mice
0302 clinical medicine
education.field_of_study
Transcranial direct-current stimulation
Naloxone
General Neuroscience
Allodynia
Hyperalgesia
Anesthesia
Neuropathic pain
medicine.symptom
Von Frey test
Pain Threshold
Morpholines
Population
Adenosine A1 Receptor Antagonists
03 medical and health sciences
Caffeine
Physical Stimulation
medicine
Animals
Nociception assay
GABA Modulators
education
Molecular Biology
business.industry
medicine.disease
Neuropathy
Antiallodynic
Disease Models, Animal
030104 developmental biology
Xanthines
Neuralgia
Pyrazoles
Central Nervous System Stimulants
Neurology (clinical)
Dizocilpine Maleate
business
Excitatory Amino Acid Antagonists
030217 neurology & neurosurgery
Developmental Biology
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Repositório Institucional do Centro Universitário La Salle, Universidade La Salle (UNILASALLE), instacron:UNILASALLE
- Accession number :
- edsair.doi.dedup.....9b2f79d29c9b313888cc35d7b876c790